Guaiacol suppresses osteoclastogenesis by blocking interactions of RANK with TRAF6 and C‐Src and inhibiting NF‐κB, MAPK and AKT pathways

Eitemau Tebyg

• Neobavaisoflavone inhibits osteoclastogenesis through blocking RANKL signalling‐mediated TRAF6 and c‐Src recruitment and NF‐κB, MAPK and Akt pathways
  gan: Chen, Huiwen, et al.
  Cyhoeddwyd: (2020)
• l‐tetrahydropalmatine suppresses osteoclastogenesis in vivo and in vitro via blocking RANK‐TRAF6 interactions and inhibiting NF‐κB and MAPK pathways
  gan: Zhi, Xin, et al.
  Cyhoeddwyd: (2019)
• 18β-Glycyrrhetinic Acid Inhibits Osteoclastogenesis In Vivo and In Vitro by Blocking RANKL-Mediated RANK–TRAF6 Interactions and NF-κB and MAPK Signaling Pathways
  gan: Chen, Xiao, et al.
  Cyhoeddwyd: (2018)
• Myostatin Promotes Osteoclastogenesis by Regulating Ccdc50 Gene Expression and RANKL-Induced NF-κB and MAPK Pathways
  gan: Zhi, Xin, et al.
  Cyhoeddwyd: (2020)
• Tereticornate A suppresses RANKL-induced osteoclastogenesis via the downregulation of c-Src and TRAF6 and the inhibition of RANK signaling pathways
  gan: Titi Liu, et al.
  Cyhoeddwyd: (2022-07-01)